• DMC Biotechnologies secured $18 million in financing co-led by Inceptional Partners and Sofinnova Partners.
• First Bight Ventures participated alongside existing investors Cibus Capital and Capricorn Partners.
• The U.S.-based health ingredients company develops high-purity bioactives using precision fermentation.
• Proceeds will accelerate commercialization of its KeyPura ingredients portfolio, support customer adoption and fund new product development.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sofinnova Partners SAS published the original content used to generate this news brief on October 26, 2026, and is solely responsible for the information contained therein.